Lynx1 Capital Management LP Acquires 663,100 Shares of GH Research PLC (NASDAQ:GHRS)

Lynx1 Capital Management LP boosted its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 15.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,858,994 shares of the company's stock after purchasing an additional 663,100 shares during the quarter. GH Research comprises 12.8% of Lynx1 Capital Management LP's investment portfolio, making the stock its 3rd biggest position. Lynx1 Capital Management LP owned about 9.34% of GH Research worth $34,013,000 at the end of the most recent reporting period.

Separately, Geode Capital Management LLC boosted its holdings in GH Research by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 72,513 shares of the company's stock worth $508,000 after purchasing an additional 3,092 shares during the last quarter. 56.90% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on GHRS shares. Stifel Nicolaus raised their target price on shares of GH Research from $18.00 to $32.00 and gave the stock a "buy" rating in a research note on Thursday, February 27th. Cantor Fitzgerald assumed coverage on shares of GH Research in a research note on Thursday, February 13th. They issued an "overweight" rating and a $14.00 price target on the stock. Guggenheim started coverage on GH Research in a research report on Thursday, March 13th. They issued a "buy" rating and a $32.00 target price on the stock. HC Wainwright restated a "buy" rating and issued a $40.00 price target on shares of GH Research in a research report on Monday, January 27th. Finally, Royal Bank of Canada started coverage on shares of GH Research in a research report on Friday, March 7th. They set an "outperform" rating and a $31.00 target price on the stock. Seven research analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of $30.86.

GH Research Trading Up 4.7 %

Shares of GH Research stock traded up $0.51 during trading hours on Friday, reaching $11.28. The stock had a trading volume of 46,676 shares, compared to its average volume of 174,495. GH Research PLC has a twelve month low of $6.00 and a twelve month high of $20.50. The stock's 50 day moving average is $10.27 and its 200 day moving average is $9.72. The firm has a market capitalization of $586.88 million, a PE ratio of -14.28 and a beta of 0.84.

GH Research (NASDAQ:GHRS - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported ($0.17) EPS for the quarter, topping analysts' consensus estimates of ($0.23) by $0.06. As a group, sell-side analysts predict that GH Research PLC will post -0.8 earnings per share for the current year.

About GH Research

GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).